New research presented at the CHEST annual meeting and published simultaneously in the New England Journal of Medicine showed that treatment with the beta blocker metoprolol failed to increase the time to exacerbation and was associated with more hospitalizations in patients with COPD without established cardiovascular indications for beta-blocker use. Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, led the Temple Lung Center’s participation in the trial. MedPage Today provided coverage of the study’s results and included comments from Dr. Criner.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH